DexCom, Inc.
DXCM
$61.14
$1.813.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.37% | 4.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.37% | 4.16% | |||
| Cost of Revenue | -5.42% | -2.30% | |||
| Gross Profit | -5.35% | 8.38% | |||
| SG&A Expenses | 8.77% | -2.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -3.12% | |||
| Operating Income | -20.96% | 33.20% | |||
| Income Before Tax | -20.90% | -3.29% | |||
| Income Tax Expenses | -4.63% | 7.15% | |||
| Earnings from Continuing Operations | -25.36% | -5.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.36% | -5.81% | |||
| EBIT | -20.96% | 33.20% | |||
| EBITDA | -16.95% | 26.82% | |||
| EPS Basic | -25.06% | -4.74% | |||
| Normalized Basic EPS | -20.57% | -2.18% | |||
| EPS Diluted | -24.43% | -3.89% | |||
| Normalized Diluted EPS | -19.84% | -1.24% | |||
| Average Basic Shares Outstanding | -0.41% | -1.13% | |||
| Average Diluted Shares Outstanding | -1.33% | -2.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||